FOLH1 and adrenal cortex carcinoma: This is a prospective head-to-head comparison of detection capability between 68 Ga-PSMA-617 and 18F-FDG PET/CT in the same group of ACC patients and the first clinical study of 177Lu-EB-PSMA-617 therapy in ACC.